Wolverine Asset Management LLC Amarin Corp Plcuk Transaction History

Wolverine Asset Management LLC

  • $4.35 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$13.94 - $24.12 $206,270 - $356,903
-14,797 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$13.89 - $23.16 $461,731 - $769,884
-33,242 Reduced 69.2%
14,797 $224,000
Q2 2019

Aug 14, 2019
SELL
$16.27 - $20.51 $300,409 - $378,696
-18,464 Reduced 27.76%
48,039 $931,000
Q1 2019

May 15, 2019
BUY
$12.61 - $22.33 $838,602 - $1.49 Million
66,503 New
66,503 $1.38 Million

Others Institutions Holding AMRN

# of Institutions
176
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email